Article thumbnail

Clinical features of H1N1 2009 infection in critically ill immunocompromised patients

By Laurent Camous, Virginie Lemiale, Emmanuel Canet, Adeline Max, David Schnell, Jerome Le Goff, Antoine Rabbat, Benoit Schlemmer and Élie Azoulay

Abstract

Seasonal influenza virus has been described as an emerging and severe pathogen in immunocompromised hosts. Since the beginning of the 2009 influenza A novel H1N1 pandemic, several series have described the clinical course of the disease in various populations. We report the clinical course of H1N1 2009 infection in 10 immunocompromised patients. Half of the patients received long-term steroid therapy. Disease was characterized by a clinical picture similar to that of non-immunocompromised patients but with prolonged course and higher mortality

Topics: Commentary
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:2887153
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2009). California Pandemic (H1N1) Working Group: Factors associated with death or hospitalization due to pandemic 2009 infl uenza A(H1N1) infection in California. JAMA
  2. (2009). Critical care services and 2009 H1N1 infl uenza in Australia and New Zealand.
  3. (2009). Critically ill patients with 2009 infl uenza A(H1N1) infection in Canada. JAMA
  4. (2007). Infection in solid-organ transplant recipients.
  5. (2002). Kusne S: Infl uenza virus infection in adult solid organ transplant recipients.